Effectiveness of plasma treatment on gastric cancer cells

Gastric Cancer

Volumn 18, Issue 3, 2015, Pages 635-643

  Torii, Koji ^a   Yamada, Suguru ^a   Nakamura, Kae ^a   Tanaka, Hiromasa ^a,b   Kajiyama, Hiroaki ^a   Tanahashi, Kuniaki ^a   Iwata, Naoki ^a   Kanda, Mitsuro ^a   Kobayashi, Daisuke ^a   Tanaka, Chie ^a   Fujii, Tsutomu ^a   Nakayama, Goro ^a   Koike, Masahiko ^a   Sugimoto, Hiroyuki ^a   Nomoto, Shuji ^a   Natsume, Atsushi ^a   Fujiwara, Michitaka ^a   Mizuno, Masaaki ^a   Hori, Masaru ^b   Saya, Hideyuki ^c   Kodera, Yasuhiro ^a   more..

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Gastric cancer; Nonthermal atmospheric pressure plasma

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; CASPASE 7; CD44V9 ANTIGEN; GLUTATHIONE; HERMES ANTIGEN; LIPOCORTIN 5; LYMPHOCYTE ANTIGEN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; PLASMA GAS;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER THERAPY; CELL FATE; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; GASTRIC CANCER CELL LINE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; NONEQUILIBRIUM ATMOSPHERIC PRESSURE PLASMA TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGED; ATMOSPHERIC PRESSURE; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PLASMA GAS; STOMACH NEOPLASMS; THERAPEUTIC USE; TUMOR CELL LINE; VERY ELDERLY;

ACETYLCYSTEINE; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; APOPTOSIS; ATMOSPHERIC PRESSURE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MIDDLE AGED; PLASMA GASES; REACTIVE OXYGEN SPECIES; STOMACH NEOPLASMS;

EID: 84915814793     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-014-0395-6     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer. 1992;70:1030–7.
3. Yu CC, Levison DA, Dunn JA, Ward LC, Demonakou M, Allum WH, et al. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer. 1995;71:1106–10.
4. Ishigami H, Kitayama J, Kaisaki S, Hidemura A, Kato M, Otani K, et al. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2010;21(1):67–70.
5. Fridman A. Plasma chemistry. Cambridge: Cambridge University Press; 2008.
6. Vandamme M, Robert E, Pesnel S, Barbosa E, Dozias S, Sobilo J, et al. Antitumor effect of plasma treatment on U87 glioma xenografts: preliminary results. Plasma Process Polym. 2010;7:264–73.
7. Yamazaki H, Ohshima T, Tsubota Y, Yamaguchi H, Jayawardena JA, Nishimura Y. Microbicidal activities of low frequency atmospheric pressure plasma jets on oral pathogens. Dent Mater J. 2011;30:384–91.
8. Fridman G, Friedman G, Gutsol A, Shekhter AB, Vasilets VN, Fridman A. Applied plasma medicine. Plasma Process Polym. 2008;5:503–33.
9. Morfill GE, Kong MG, Zimmermann JL. Focus on plasma medicine. New J Phys. 2009;11(11):115011.
10. Yousfi M, Merbahi N, Pathak A, Eichwald O. Low-temperature plasmas at atmospheric pressure: toward new pharmaceutical treatments in medicine. Fundam Clin Pharmacol. 2013. doi:10.1111/fcp.12018.
11. Brun P, Brun P, Vono M, Venier P, Tarricone E, Deligianni V, et al. Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma. PLoS ONE. 2012;7(3):e33245.
12. Fridman G, Peddinghaus M, Balasubramanian M, Ayan H, Fridman A, Gutsol A, et al. Blood coagulation and living tissue sterilization by floating-electrode dielectric barrier discharge in air. Plasma Chem Plasma Process. 2006;26:425–42.
13. Lee JK, Kim, Byun JH, Kim KT, Kim GC, Park GY. Biochemical applications of low temperature atmospheric pressure plasmas to cancerous cell treatment and tooth breaching. Jpn J Appl Phys. 2011;50:08JF01.
14. Sato T, Yokoyama M, Johkura K. A key inactivation factor of HeLa cell viability by a plasma flow. J Phys D Appl Phys. 2011;44(37):372001.
15. Sensenig R, Kalghatgi S, Cerchar E, Fridman G, Shereshevsky A, Torabi B, et al. Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species. Ann Biomed Eng. 2011;39:674–87. Retraction in: Ann Biomed Eng. 2013;41(3):656.
16. Utsumi F, Kajiyama H, Nakamura K, Tanaka H, Mizuno M, Ishikawa K, et al. Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo. PLoS ONE. 2013;8(12):e81576.
17. Iseki S, Nakamura K, Hayashi M, Tanaka H, Kondo H, Kajiyama H, et al. Selective killing of ovarian cancer cells through induction of apoptosis by nonequilibrium atmospheric pressure plasma. Appl Phys Lett. 2012;100(11):113702.
18. Ito T, Yamada S, Tanaka C, Ito S, Murai T, Kobayashi D, et al. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer. Ann Surg Oncol. 2014;21(2):560–8.
19. − and thereby promotes tumor growth. Cancer Cell. 2011;19:387–400.
20. Kim CH, Kwon S, Bahn JH, Lee K, Jun SI, Rack PD, et al. Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cells. Appl Phys Lett. 2010;96(24):243701.
21. Fridman G, Shereshevsky A, Jost M, Brooks A, Fridman A, Gutsol A, et al. Floating electrode dielectric barrier discharge plasma in air promoting apoptotic behavior in melanoma skin cancer cell lines. Plasma Chem Plasma Process. 2007;27:163–76.
22. Tanaka H, Mizuno M, Ishikawa K, Nakamura K, Kajiyama H, Kano H, et al. Plasma-activated medium selectively kills glioblastoma brain tumor cells by down-regulating a survival signaling molecule, AKT kinase. Plasma Med. 2011;1(3–4):265–77.
23. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34–43.
24. Heiss MM, Murawa P, Koralewski P, Kutarsa E, Kolesnik OO, Ivanchenko VV, et al. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial. Int J Cancer. 2010;127:2209–21.
25. Ma R, Feng H, Li F, Liang Y, Zhang Q, Zhu W, et al. An evaluation of anti-oxidative protection for cells against atmospheric pressure cold plasma treatment. Appl Phys Lett. 2012;100(12):123701.
26. Ninomiya K, Ishijima T, Imamura M, Yamahara T, Enomoto H, Takahashi K, et al. Evaluation of extra- and intracellular OH radical generation, cancer cell injury, and apoptosis induced by a non-thermal atmospheric-pressure plasma jet. J Phys D Appl Phys. 2013;46(42):425401.
27. 2 but independent of cellular ROS production in prostate cancer cells. Mutat Res. 2011;716(1–2):40–50.
28. Jang BI, Li Y, Graham DY, Cen P. The role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancer. Gut Liver. 2011;5(4):397–405.
29. Liu J, Ma L, Xu J, Liu C, Zhang J, Liu J, et al. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties. Int J Oncol. 2013;42(2):453–9.
30. Mayer B, Jauch KW, Gunthert U, Figdor CG, Schildberg FW, Funke I, et al. De novo expression of CD44 and survival in gastric cancer. Lancet. 1993;342(8878):1019–22.
31. Shibuya Y, Okabayashi T, Oda K, Tanaka N. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma. Jpn J Clin Oncol. 1998;28(10):609–14.
32. Györffy B, Schäfer R. Biomarkers downstream of RAS: a search for robust transcriptional targets. Curr Cancer Drug Targets. 2010;10:858–68.
33. Yoshida GJ, Saya H. Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. Biochem Biophys Res Commun. 2014;443(2):622–7.
34. Nicco C, Laurent A, Chereau C, Weill B, Batteux F. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother. 2005;59(4):169–74.